A major drug testing scandal breaks out in a cozy lakeside community . . . [read more]

Swiss biotech startup Zuritech circumvents the FDA to launch a blockbuster drug that will score them billions . . . [read more]

The merger of two medical technology companies teeters in the wake of a brutal attack on an investment banker . . . [read more]

The death of a high level FDA official leads to an investigation into a new psychiatric drug . . . [read more]

Dennis Carr is author of four novels. His latest, 2nd Chance, is a medical mystery about Tranquil Rx, a breakthrough drug in the multi-billion dollar psych market. He and his wife live in Atlanta.